AI assistant
GALECTIN THERAPEUTICS INC — Director's Dealing 2013
Nov 5, 2013
33422_dirs_2013-11-05_c786b082-8b04-4203-9037-2ae7540464f3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2013-11-01
Reporting Person: 10X Fund, L.P. (10% Owner)
Reporting Person: 10X Capital Management, LLC (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-01 | Common Stock | M | 150000 | $3.00 | Acquired | 9407422 | Direct |
| 2013-11-01 | Common Stock | M | 50000 | $3.00 | Acquired | 9457422 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-11-01 | Class A-2 Warrants (right to buy) | $3.00 | M | 150000 | Disposed | 2019-05-13 | Common Stock (150000) | Direct |
| 2013-11-01 | Class A-2 Warrants (right to buy) | $3.00 | M | 50000 | Disposed | 2019-06-30 | Common Stock (50000) | Direct |
Footnotes
F1: 10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
F2: On May 13, 2009, 10X Fund, L.P. purchased (a) 450,000 shares of Series B-2 Preferred Stock, (b) one Class A-1 Warrant to purchase 150,000 shares of Common Stock for $3.00 per share, (c) one Class A-2 Warrant to purchase 150,000 shares of Common Stock for $3.00 per share, and (d) one Class B Warrant to purchase 600,000 shares of Common Stock for $3.00 per share, for aggregate consideration of $900,000.
F3: On June 30, 2009, 10X Fund, L.P. purchased (a) 250,000 shares of Series B-2 Preferred Stock, (b) one Class A-1 Warrant to purchase 833,333 shares of Common Stock for $3.00 per share, (c) one Class A-2 Warrant to purchase 83,333 shares of Common Stock for $3.00 per share, and (d) one Class B Warrant to purchase 333,333 shares of Common Stock for $3.00 per share, for aggregate consideration of $500,000.